Related Experiment Video
Updated: Sep 25, 2026
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
[Study on mechanisms of human gastric carcinoma cells apoptosis induced by genistein]
Danfeng Song1, Xiaolin Na, Ying Liu
1Public Health School, Harbin Medical University, Harbin 150001, China.
Abstract:
In order to study the apoptosic effect of genistein on human gastric carcinoma SGC-7901 cells, DAPI dyeing and DNA electrophoresis were used. Western Blot was used to detect the changes of the expression of p53 protein, Caspase-3 after SGC-7901 cells were exposed to genistein. The results showed that genistein induced cell apoptosis. Genistein also decreased the expression of mutant p53, and increased the protein expression of Caspase-3. These indicated that genistein could induce the apoptosis of gastric carcinoma cells. The inhibition of the expression of mutant p53 and enhance of the protein expression of Caspase-3 would be possible mechanism.
Insights
Genistein triggers apoptosis in human gastric cancer cells by reducing mutant p53 and increasing Caspase-3 protein levels. This study explores genistein
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Context:
- Human gastric carcinoma SGC-7901 cells are a model for studying gastric cancer.
- Genistein is a soy isoflavone with potential anti-cancer properties.
- Apoptosis is programmed cell death, a crucial process in cancer therapy.
Purpose:
- To investigate the apoptotic effects of genistein on human gastric carcinoma SGC-7901 cells.
- To determine the impact of genistein on p53 protein expression and Caspase-3 activation.
- To elucidate the molecular mechanisms underlying genistein-induced apoptosis.
Summary:
- Genistein treatment induced apoptosis in SGC-7901 cells, confirmed by DAPI staining and DNA electrophoresis.
- Western blot analysis revealed that genistein decreased the expression of mutant p53 protein.
- Genistein significantly increased the protein expression of Caspase-3, an executioner caspase.
Impact:
- Genistein demonstrates potential as a therapeutic agent for gastric cancer.
- The findings suggest that inhibiting mutant p53 and enhancing Caspase-3 are key mechanisms of genistein's action.
- This research provides a basis for further investigation into genistein-based gastric cancer treatments.